{
    "2018-02-02": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Noteworthy ETF Inflows: XLV, JNJ, TMO, LLY",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflows",
                        "XLV",
                        "JNJ",
                        "TMO",
                        "LLY"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Celgene: Pomalyst and Otezla’s Revenue Trends in 4Q17",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Pomalyst",
                        "Otezla",
                        "Revenue",
                        "4Q17"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Johnson & Johnson’s Valuation after Its 4Q17 Earnings",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Valuation",
                        "4Q17",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}